ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Vincerx Inc

Vincerx Inc (VINC)

0.73
-0.1667
(-18.59%)
Closed April 28 4:00PM
0.752
0.022
(3.01%)
After Hours: 7:39PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.752
Bid
0.73
Ask
2.00
Volume
1,728,731
0.6607 Day's Range 0.846001
0.61 52 Week Range 9.3722
Market Cap
Previous Close
0.8967
Open
0.79
Last Trade
20
@
0.7301
Last Trade Time
Financial Volume
$ 1,379,221
VWAP
0.797823
Average Volume (3m)
1,220,061
Shares Outstanding
21,380,570
Dividend Yield
-
PE Ratio
-10.12
Earnings Per Share (EPS)
-1.88
Revenue
-
Net Profit
-40.16M

About Vincerx Inc

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2021
Vincerx Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VINC. The last closing price for Vincerx was $0.90. Over the last year, Vincerx shares have traded in a share price range of $ 0.61 to $ 9.3722.

Vincerx currently has 21,380,570 shares outstanding. The market capitalization of Vincerx is $406.23 million. Vincerx has a price to earnings ratio (PE ratio) of -10.12.

VINC Latest News

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering of (i) 6,000,000 shares of its common...

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of shares of its common stock and accompanying...

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 

VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily pretreated patients with metastatic solid tumors...

Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...

Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

VIP236, first-in-class small molecule-drug conjugate (SMDC), preliminary Phase 1 data and update on pipeline progress will be presented by management at a virtual investor event on April 8 at 2:00...

Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1247-14.22379377210.87670.99420.66074307750.90229506CS
4-4.138-84.62167689164.896.840.660717101531.71284702CS
12-0.528-41.251.289.37220.660712200613.15658442CS
26-0.2474-24.75485291170.99949.37220.618337342.5485637CS
52-0.498-39.841.259.37220.614700622.39142436CS
156-15.608-95.403422982916.3618.42650.612423463.68409611CS
260-19.368-96.262425447320.1226.750.612272094.32793228CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

VINC Discussion

View Posts
Laster Laster 2 days ago
What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Can’t believe they didn’t try to do the financing when it was trading above $5.
👍️0
RAlbert RAlbert 2 weeks ago
Tomorrow will be $1.50
👍️0
RAlbert RAlbert 2 weeks ago
No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life
👍️0
RAlbert RAlbert 3 weeks ago
Blood bath. I should have waited one more day.
👍️0
Monksdream Monksdream 3 weeks ago
Somebody knows something you don’t
👍️0
RAlbert RAlbert 3 weeks ago
I don’t find the price and volume the capital raise is. Am I missing anything here?
👍️0
Monksdream Monksdream 3 weeks ago
Check for SEC filings
👍️0
RAlbert RAlbert 3 weeks ago
Is the capital raise 80% discounted to yesterday price? Insane
👍️0
Monksdream Monksdream 3 weeks ago
Check for a capital raise which means dilution
👍️0
RAlbert RAlbert 3 weeks ago
Wonder why there is a steep fall in price when the results are not negative.
👍️0
RAlbert RAlbert 3 weeks ago
Wonder why there is a steep fall in price when the results are not negative.
👍️0
Monksdream Monksdream 4 weeks ago
VINC 10Q due 4/3
👍️0
Monksdream Monksdream 1 month ago
VINC 10Q due 3/25
Next day settlement 5/28 per SEC mandate
👍️0
Monksdream Monksdream 2 months ago
VINC new 52.week hi
👍️0
Monksdream Monksdream 2 months ago
VINC new 52 week high
👍️0
Monksdream Monksdream 2 months ago
VINC in the Barchart Top 10
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
Tom turtles Tom turtles 2 months ago
Very nice surprise...🆙⬆️
👍️0
Monksdream Monksdream 2 months ago
VINC new 52 week high
👍️0
glenn1919 glenn1919 2 months ago
VINC..................................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 2 months ago
160k wall getting gobbled up
👍️0
Awl416 Awl416 2 months ago
Another leg. Damn
👍️0
Awl416 Awl416 2 months ago
Who’s poking it?
👍️0
Monksdream Monksdream 2 months ago
VINC under $2
👍️0
make it happen make it happen 4 months ago
It's deficient. Failed to meet NASDAQs listing requirements. I'm expecting a reverse split in the future.
👍️0
alchemytrader alchemytrader 4 months ago
moving...
👍️0
Monksdream Monksdream 7 months ago
VINC under $2
👍️0

Your Recent History

Delayed Upgrade Clock